FDA 483 - Scott R. Bartley, M.D. - February 17, 2023

An FDA inspection of Scott R. Bartley, MD, Clinical Investigator in Richardson, TX, revealed a significant deviation from an investigational plan. The primary issue involved the incorrect administration of doses to multiple subjects in a clinical study due to a dispensing error. This indicates a failure to adhere to protocol requirements during the investigation.